Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-055881

Chief Legal Officer sold 12,500 shares at $50.00 ($625,000)

  • Chief Legal Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Siegel Jolie Chief Legal Officer 2021-09-10 Option exercise +12,500 $4.98 $62,250 12,500 D
Siegel Jolie Chief Legal Officer 2021-09-10 Sale −12,500 $50.00 $625,000 0 D
Derivatives
Siegel Jolie Chief Legal Officer 2021-09-10 Option exercise · Stock Option (Right to Buy) −12,500 271,321 D
Open-market sales · 12,500 sh · avg $50.00 · $625,000
Loading xslF345X03/doc4.xml…